A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer
新型 CDK4/6 和 PARP 双重抑制剂 ZC-22 可有效抑制肿瘤生长并改善乳腺癌和卵巢癌对顺铂治疗的反应
期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms23052892
Chenchen Tian, Yufan Wei, Jianjun Li, Zhi Huang, Qiong Wang, Yingxue Lin, Xingping Lv, Yanan Chen, Yan Fan, Peiqing Sun, Rong Xiang, Antao Chang, Shuang Yang